Day: May 14, 2017

New MS Drug Ocrevus Wins FDA Approval

The Food and Drug Administration approved a new drug to treat multiple sclerosis Tuesday. The drug, called Ocrevus, is approved for use against the most common form of MS – the relapsing-remitting type. It’s also the first drug specifically approved for primary progressive MS, a very aggressive form of the […]